Max Robotics — Global Service Robot Directory + US Certification

About

Salvatore Guaglianone is a pioneering urologic surgeon whose work has fundamentally advanced the field of robotic surgery, particularly in complex oncologic procedures. His research centers on minimally invasive techniques for radical cystectomy, partial nephrectomy, and prostate surgery, with a focus on eliminating renal ischemia and improving patient quality of life. Guaglianone has been instrumental in developing and validating totally intracorporeal urinary diversion during robot-assisted radical cystectomy, demonstrating through randomized controlled trials that this approach can match or surpass open surgery in oncologic and functional outcomes—work that has garnered over 100 citations for his seminal 2016 paper on the Padua ileal bladder. His innovative "off-clamp" partial nephrectomy techniques, using indocyanine green fluorescence and controlled hypotensive anesthesia to avoid hilar clamping, have preserved renal function in tumors larger than 4 cm, with 76 citations for his 2018 "Ride the Green Light" study. With over 600 total citations across his top ten papers, Guaglianone has also contributed to the history of robotic surgery from PROBOT to HUGO, and his recent 2024 randomized trial continues to shape evidence-based practice. His work stands as a benchmark for combining technical innovation with rigorous clinical validation.